Hi-Clearance - Asset Resilience Ratio
Hi-Clearance (1788) has an Asset Resilience Ratio of 2.55% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hi-Clearance short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Hi-Clearance's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Hi-Clearance (1788) total assets.
Liquid Assets Composition Over Time
This chart breaks down Hi-Clearance's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 1788 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$127.12 Million | 2.55% |
| Total Liquid Assets | NT$127.12 Million | 2.55% |
Asset Resilience Insights
- Limited Liquidity: Hi-Clearance maintains only 2.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hi-Clearance Industry Peers by Asset Resilience Ratio
Compare Hi-Clearance's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Hi-Clearance (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Hi-Clearance.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.63% | NT$130.66 Million ≈ $4.12 Million |
NT$4.96 Billion ≈ $156.28 Million |
+0.23pp |
| 2023-12-31 | 2.40% | NT$110.86 Million ≈ $3.49 Million |
NT$4.62 Billion ≈ $145.49 Million |
+0.34pp |
| 2022-12-31 | 2.06% | NT$93.01 Million ≈ $2.93 Million |
NT$4.51 Billion ≈ $142.05 Million |
+0.72pp |
| 2021-12-31 | 1.34% | NT$59.55 Million ≈ $1.88 Million |
NT$4.44 Billion ≈ $139.80 Million |
-0.12pp |
| 2020-12-31 | 1.47% | NT$61.65 Million ≈ $1.94 Million |
NT$4.20 Billion ≈ $132.42 Million |
-0.55pp |
| 2019-12-31 | 2.01% | NT$75.07 Million ≈ $2.37 Million |
NT$3.73 Billion ≈ $117.42 Million |
-2.36pp |
| 2018-12-31 | 4.38% | NT$129.95 Million ≈ $4.09 Million |
NT$2.97 Billion ≈ $93.55 Million |
-1.10pp |
| 2017-12-31 | 5.48% | NT$143.14 Million ≈ $4.51 Million |
NT$2.61 Billion ≈ $82.33 Million |
-1.20pp |
| 2016-12-31 | 6.68% | NT$165.10 Million ≈ $5.20 Million |
NT$2.47 Billion ≈ $77.85 Million |
-- |
About Hi-Clearance
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more